ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Det aktuella priset för CDXC är $7.87 USD — det har minskat med -0.88% under de senaste 24 timmarna. Följ ChromaDex-aktiens utveckling närmare i diagrammet.
Vad är ChromaDexs aktiesymbol?▼
Beroende på börsen kan aktiesymbolen variera. Till exempel handlas ChromaDex-aktien på börsen under symbolen CDXC.
Vad var ChromaDexs intäkter förra året?▼
ChromaDexs intäkter för det senaste året uppgår till 99.6M USD.
Vad var ChromaDexs nettoresultat förra året?▼
CDXCs nettovinst för det senaste året är 8.55M USD.
Hur många anställda har ChromaDex?▼
Från och med april 01, 2026 har företaget 104 anställda.
I vilken sektor finns ChromaDex?▼
ChromaDex verkar inom sektorn Health Care.
När genomförde ChromaDex en aktiesplit?▼
Den senaste aktiesplitten för ChromaDex var den april 13, 2016 med ett förhållande på 1:3.